Biotechnology Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Biotechnology
Ginkgo Bioworks Holdings Inc (DNA) Q3 2024 Earnings Call Highlights: Strategic Restructuring and Revenue Growth Amid Challenges
Ginkgo Bioworks Holdings Inc (DNA) reports improved adjusted EBITDA and reduced expenses, while navigating biosecurity revenue volatility and restructuring impacts. Nov 13, 2024
GuruFocus News Biotechnology
Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Initiatives
Theravance Biopharma Inc (TBPH) reports robust quarterly sales growth and outlines strategic plans to enhance shareholder value amidst market challenges. Nov 13, 2024
GuruFocus News Biotechnology
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions
FibroGen Inc (FGEN) reports a significant increase in Roxadustat sales in China and a substantial reduction in operating expenses, despite facing potential generic competition and a net loss. Nov 13, 2024
GuruFocus News Biotechnology
Dyadic International Inc (DYAI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Collaborations Drive Growth
Despite a net loss, Dyadic International Inc (DYAI) showcases significant revenue growth and promising partnerships in the biopharmaceutical sector. Nov 13, 2024
GuruFocus News Biotechnology
Lexicon Pharmaceuticals Inc (LXRX) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory Challenges
Lexicon Pharmaceuticals Inc (LXRX) showcases progress in clinical developments and strategic partnerships, while navigating regulatory hurdles and financial pressures. Nov 13, 2024